NIH/FDA/DOD interagency working group on oxygen therapeutics

2Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Research and development in the field of oxygen therapeutics has made substantial progress in the past two decades. However, significant challenges have been encountered, as highlighted at an NIH/FDA/HHS workshop in 2008.

Cite

CITATION STYLE

APA

Mitchell, P., Weiskopf, R., & Zapol, W. M. (2013). NIH/FDA/DOD interagency working group on oxygen therapeutics. In Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics (Vol. 9783642407178, pp. 141–147). Springer-Verlag Berlin Heidelberg. https://doi.org/10.1007/978-3-642-40717-8_8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free